Speech Pathology Australia Annual Report 2023

5. REVENUE The Company’s revenue may be analysed as follows for each major product and service category: 2023

2022

$

$

REVENUE MEMBER SERVICES Member subscriptions Publication income

5,926,141

5,329,723

89,489 142,173 293,691 82,002 635,608 660,673 646,615 87,158

95,329 100,055 208,799 77,715 532,000 537,670 606,231 150,775

Eligibility fees

Insurance administration fees

Member services

Continuing education

Conference

Professional resources and services

Copyright royalties Resource guide

118

659

8,563,668

7,638,956

OTHER INCOME Rent

0

108,429 49,485 104,901 (74,652) 188,163 7,827,119

Interest Grants

128,740 28,590 60,570 217,900

Net unrealised gain/(loss) on Financial Assets at FVTPL

8,781,568

2023

2022

$

$

REVENUE Point over time

5,926,141 2,855,427 8,781,568

5,329,723 2,497,396 7,827,119

Point in time

6. CASH AND CASH EQUIVALENTS Cash and cash equivalents consist the following:

2023

2022

$

$

Cash at bank

1,651,200

2,475,907

Short term deposits (< 3 months)

508,219

0

Cash on hand

500

500

Cash and cash equivalents

2,159,919

2,476,407

6.1 Reconciliation of cash Cash at the end of the financial year as shown in the statement of cash flows is reconciled in the statement of financial position as follows: 2023 2022 $ $ Cash and cash equivalents 2,159,919 2,476,407

2023 Annual Report | Speech Pathology Australia 37